Biological Indicators Market Report
The Global Biological Indicators Market is segmented By Type (Self-Contained Biological Indicator, Biological Indicator Strip), By End-Use (Hospital, Pharmaceutical Companies, Others), and Region. This market research report provides in-depth information on trends, dynamics, revenue opportunities, competitive landscape, and recent developments in the global biological indicators market. The historic years considered for the study are 2016-2019, the base year is 2020, the estimated year is 2021, and the forecast period is 2022-2026.
The Global Biological Indicators Market is segmented By Type (Self-Contained Biological Indicator, Biological Indicator Strip), By End-Use (Hospital, Pharmaceutical Companies, Others), and Region. This market research report...
Covid-19 has impacted the market dynamics, competition, and global supply chain. The revenues have gone down in 2020 and may resume an uptrend gradually from 2021. Companies optimizing their operation and strategy will sustain and beat the competition.
Note: The summary below might not have included insights on covid impact since we have large number of reports.
The Global Biological Indicators Market is projected to grow from USD 345.2 million in 2020 to USD 480.7 million by 2026 at a CAGR of over 5.7% during the forecast period.
Biological Indicators are as defined by ISO and ANSI/AAMI are test systems containing viable microorganisms offering a defined resistance to a specific sterilization process. A biological indicator provides information on whether necessary conditions were met to kill a specified number of microorganisms for a given sterilization process, offering a level of confidence in the process.
Key players operating in the global biological indicators market are-
Biological indicators exhibit reliable results when compared to chemical indicators, thus drives the product preference.
By end-use, the biological indicators market has been segmented into hospitals, pharmaceutical companies, and others. Under these, the hospital segment held a substantial market share in 2020 and is likely to register the fastest CAGR in the following years. This is mainly attributed to growing sterilization procedures that are repeatedly carried out in hospitals. Moreover, stringent regulatory guidelines for sterilization of biologics, medical devices, and drugs are propelling the biological indicators market.
By region, the market in the North America garnered a significant market share in 2020 and is projected to grow at a steady CAGR during the assessment period.
This is mainly attributed to advanced healthcare infrastructure, increasing awareness among population, growing favourable government initiatives and increasing prevalence of diseases due to a change in lifestyle, which further augments the regional growth.
The ongoing COVID-19 pandemic has positively influenced the biological indicators industry due to the increasing surge of coronavirus cases across the globe. The rising epidemiological numbers around the world create a surging need for biological indicators, thus boosting the product demand.
Wish to know more about the study? Get a customised report here.
Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected].
The biological indicators market is expected to witness an impressive growth of 5.7% CAGR in the foreseeable future.
3M (The U.S), Getinge Group (Sweden), Cantel Medical (The U.S), Mesa Laboratories (The U.S), Steris (The U.S), Fuze Medical (The U.S), Matachana (Spain), Hu-Friedy (The U.S), Advanced Sterilization (The U.S) and Bag Health Care (Germany) are among the key players in the biological indicators market.
The biological indicators market is expected to reach USD 480.7 million in the coming years.
Rise in R&D activities coupled with strict government regulations, growing demand for medical devices and medicines owing to the high prevalence of chronic diseases are the factors driving the growth of biological indicators market.
The hospital segment is expected to register the fastest CAGR in the biological indicators market in the following years.
Biological indicators companies, Biological indicators vendors, R&D centers, Laboratory clinics, Hospitals are the target audience in the biological indicators market